"It provides a simple getaway to investigate liver damage. It channels us to use expensive investigations like fibroscan or MRI preferentially in those people who have acanthosis nigricans vs. those ...
Recruitment in NATiV3 clinical trial progresses with over 85% of the targeted number of patients enrolled in the main cohort and a statistical powering of the study expected to be superior to 95% for ...